Market Tracker

10/23 5:16pm ET

Novartis AG (NYSE:NVS)

85.91
Delayed Data
As of Oct 23
 +0.17 / +0.20%
Today’s Change
66.93
Today|||52-Week Range
86.90
+17.94%
Year-to-Date
Gilead Drug Approval Fuels Interest in CAR-T Space: 3 Stocks to Consider
Oct 23 / Zacks.com - Paid Partner Content
Glaxo (GSK) Q3 Earnings: Will it Deliver a Beat Yet Again?
Oct 20 / Zacks.com - Paid Partner Content
Key Predictions for Q3 Earnings Reports of LLY, BIIB, NVS
Oct 23 / Zacks.com - Paid Partner Content
What's in the Cards for Amgen (AMGN) this Earnings Season?
Oct 20 / Zacks.com - Paid Partner Content
Roche (RHHBY) Reports Sales Numbers for First 9 Months
Oct 20 / Zacks.com - Paid Partner Content
Conatus' Liver Disease Drug Gets Orphan Drug Tag in the EU
Oct 20 / Zacks.com - Paid Partner Content
Gilead (GILD) CAR-T Therapy Yescarta Clinches FDA Approval
Oct 20 / Zacks.com - Paid Partner Content
Can ImmunoGen's Key Pipeline Cancer Candidate Drive Growth?
Oct 19 / Zacks.com - Paid Partner Content
Cancer Treatment Update: Second Gene Therapy Receives Approval
Oct 20 / Zacks.com - Paid Partner Content
Conatus Entrusts Keith W. Marshall With Key Management Roles
Oct 19 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close85.74
Today’s open86.22
Day’s range85.80 - 86.59
Volume4,253,339
Average volume (3 months)1,688,462
Market cap$200.9B
Dividend yield3.16%
Data as of 4:02pm ET, 10/23/2017

Growth & Valuation

Earnings growth (last year)-61.91%
Earnings growth (this year)--
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)-1.90%
P/E ratio31.4
Price/Sales3.61
Price/Book2.70

Competitors

 Today’s
change
Today’s
% change
PFEPfizer-0.02-0.05%
MRKMerck-0.48-0.75%
SNYSanofi+0.11+0.22%
ABBVAbbVie-1.59-1.65%
Data as of 4:02pm ET, 10/23/2017

Financials

Last reporting dateOctober 24, 2017
EPS forecast (this quarter)$1.23
Annual revenue (last year)$48.4B
Annual profit (last year)$6.7B
Net profit margin13.83%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
Joseph Jimenez
Chief Financial Officer
Harry Kirsch
Corporate headquarters
Basel, Basel-stadt (basle Town)

Forecasts